Power Law company profile

Abridge

Health Tech & Medtech · San Francisco, United States · Founded 2018 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5–10B

Latest valuation · 2026

Unlock exact value

Revenue

<$1M

Latest reported FY

Unlock exact value

Headcount

500–1k

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Machine learning technology that powers ability to highlight key points and integrate insights that help people understand their care

Investors

32 investors on Abridge's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 5 investors entered at this stage

EMC

KdT Ventures

Venrock

Bessemer Venture Partners

Angel Investors Network

Series A 12 investors entered at this stage

The University of Pittsburgh Medical Center

Zen Chu

Esther Dyson

Whistler Capital Partners

Pillar Ventures

Pillar VC

UPMC Enterprises

IKS Health

Wittington Ventures

Union Square Ventures

Aneesh Chopra

Yoshua Bengio

Series B+ 15 investors entered at this stage

CVS Health Ventures

NVentures

Lightspeed Venture Partners

Mass General Brigham Ventures

California HealthCare Foundation

Kaiser Permanente Ventures

Spark Capital

Andreessen Horowitz

SV Angel

K-ventures

Global footprint

Where Abridge has talent and traffic

AI talent share

3.7% of workforce is AI talent
(20 of 547 staff)

Core AI173.11%

Other AI30.55%

Non-AI workforce52796.34%

Workforce by country

3 countries with
team presence

🇺🇸 United States97.1%

🇨🇦 Canada2.3%

🇧🇷 Brazil0.4%

3 countries shown

Web traffic by country

210K monthly visits
across markets

🇺🇸 United States74.5%

🇮🇳 India4.1%

🇨🇦 Canada3.4%

🇬🇧 United Kingdom1.8%

🇮🇩 Indonesia1.3%

Top 5 markets shown

Patent intelligence

$12k patent portfolio · 3 active families

Estimated portfolio value

$12k

<0.01% of valuation · 6217.5× smaller than top peer Dental Monitoring ($73M)

3 active patent families

Where Abridge innovates Natural languageLearning modelsData scienceMultimediaSystems analysis

Where Abridge concentrates vs peers

Each axis is a top-10 topic across Abridge and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Abridge

An AI-synthesized read of the highest-engagement posts about Abridge on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abridge on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles